DERMATOPLEX
LIVE

Serial Number

79377981

Owner

SpeeDx Pty Ltd

Attorney

Jefferson F. Scher

Filing Date

Jul 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DERMATOPLEX Trademark

Serial Number: 79377981 • Registration: 7894983

DERMATOPLEX is a trademark filed by SpeeDx Pty Ltd on July 31, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SpeeDx Pty Ltd (21 trademarks)

Suite G16, National Innovation Centre,

Entity Type: 82

Trademark Details

Filing Date

July 31, 2023

Registration Date

August 19, 2025

Published for Opposition

June 3, 2025

Goods & Services

Surgical, medical and veterinary apparatus and instruments for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic testing apparatus and instruments for medical purposes, namely, for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical diagnostic apparatus for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Anatomic pathology specimen collection kit comprising glass slides, centrifuge tubes, formalin jars, coplin jars, insert to hold slides and jars, absorbent cloth, and printed instructions, all for medical use

Chemical reagents for non-medical purposes; chemical reagents for scientific purposes; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; enzyme preparations for industrial purposes to identify pathogens, infections, and infectious diseases; enzymes for scientific and research purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; acids, namely, nucleic recombinant acids to identify pathogens, infections, and infectious diseases for scientific purposes; polymerase for scientific purposes; none of the foregoing for use in promoting plant growth or in enhancing the effectiveness of plant nutrients

Scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; research and development services in the field of chemistry; scientific research in the field of chemistry; research in the field of chemistry; research laboratory analysis services in the field of chemistry; development services in the field of medical diagnostic apparatuses; design of medical diagnostic apparatuses; research in the field of molecular sciences; data analysis for scientific research purposes in the field of scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services, for scientific research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific research purposes; providing reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services, for scientific research purposes; custom design and development of biochemical assays

Medical services; human healthcare services in the field of diagnosis and identification of pathogens infections and infectious diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services in the field of DNA and genetic testing; medical diagnostic services in the nature of medical testing and analysis; molecular diagnostics testing for medical purposes; providing medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; analysis of medical diagnostic images and medical molecular tests for medical purposes

Reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use to identify pathogens, infections, and infectious diseases; chemical preparations containing enzymes for medical purposes for treating infections and infectious diseases; chemical preparations containing enzymes for treating infections and infectious diseases for pharmaceutical, veterinary and medical purposes; enzyme preparations for pharmaceutical, veterinary and medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; diagnostic kits comprising diagnostic agents, preparations and substances for medical and veterinary use; diagnostic kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, all for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; none of the foregoing for use in or as a medicated shampoo

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 19, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 19, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 4, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 11, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 11, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 11, 2025 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 9, 2025 OPNR
ASSIGNED TO EXAMINER
Jan 13, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 22, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 22, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 22, 2024 COAR
ATTORNEY REVIEW COMPLETED
Aug 12, 2024 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jul 7, 2024 LIME
REFUSAL PROCESSED BY IB
May 13, 2024 RFNT
LIMITATION OF GOODS RECEIVED FROM IB
May 12, 2024 LIMG
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 23, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 4, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 3, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 12, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2023 REPR